Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark. (2020)
Attributed to:
Lifecourse Determinants of Bone and Joint Disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11657-020-00746-z
PubMed Identifier: 32483674
Publication URI: http://europepmc.org/abstract/MED/32483674
Type: Journal Article/Review
Volume: 15
Parent Publication: Archives of osteoporosis
Issue: 1